WallStreetZenWallStreetZen

NYSE: OGN
Organon & Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for OGN

Based on 3 analysts offering 12 month price targets for Organon & Co

Min Forecast
$8.00+25.2%
Avg Forecast
$9.67+51.28%
Max Forecast
$12.00+87.79%

Should I buy or sell OGN stock?

Based on 3 analysts offering ratings for Organon & Co.

Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
2 analysts 66.67%
Although OGN's forecast from analysts indicates a "Strong Sell", our proven Zen Rating quant model rates OGN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their OGN stock forecasts and price targets.

OGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-24
lockedlocked$00.00+00.00%2025-11-11
lockedlocked$00.00+00.00%2025-11-11

1 of 1

Forecast return on equity

Is OGN forecast to generate an efficient return?

Company
132.86%
Industry
-52.02%
Market
180.26%
OGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OGN forecast to generate an efficient return on assets?

Company
7.76%
Industry
27.43%
OGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OGN earnings per share forecast

What is OGN's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$3.50+386.28%
Avg 2 year Forecast
$3.76+421.72%
Avg 3 year Forecast
$4.21+485.24%
OGN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

OGN revenue forecast

What is OGN's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$6.2B+0.42%
Avg 2 year Forecast
$6.3B+2.09%
Avg 3 year Forecast
$6.4B+3.19%
OGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OGN earnings growth forecast

How is OGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
79.6%
Industry
30.76%
Market
36.23%
OGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
OGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
OGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

OGN revenue growth forecast

How is OGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
1.09%
Industry
9.11%
Market
13.48%
OGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OGN vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
OGN$6.39$9.67+51.28%Strong Sell
AMRN$15.52N/AN/A
SCLX$8.16N/AN/A
MIRA$1.17N/AN/A
NSRX$2.79$20.50+634.77%Strong Buy
View Top General Drug Manufacturer Stocks

Organon & Co Stock Forecast FAQ

Is Organon & Co Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: OGN) stock is to Strong Sell OGN stock.

Out of 3 analysts, 0 (0%) are recommending OGN as a Strong Buy, 0 (0%) are recommending OGN as a Buy, 1 (33.33%) are recommending OGN as a Hold, 0 (0%) are recommending OGN as a Sell, and 2 (66.67%) are recommending OGN as a Strong Sell.

If you're new to stock investing, here's how to buy Organon & Co stock.

What is OGN's earnings growth forecast for 2026-2028?

(NYSE: OGN) Organon & Co's forecast annual earnings growth rate of 79.6% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 30.76%, and it is also forecast to beat the US market's average forecast earnings growth rate of 36.23%.

Organon & Co's earnings in 2026 is $187,000,000.On average, 8 Wall Street analysts forecast OGN's earnings for 2026 to be $911,417,154, with the lowest OGN earnings forecast at $846,962,999, and the highest OGN earnings forecast at $1,016,792,929. On average, 8 Wall Street analysts forecast OGN's earnings for 2027 to be $977,849,708, with the lowest OGN earnings forecast at $900,535,960, and the highest OGN earnings forecast at $1,076,925,844.

In 2028, OGN is forecast to generate $1,096,892,054 in earnings, with the lowest earnings forecast at $971,966,574 and the highest earnings forecast at $1,213,591,560.

What is OGN's revenue growth forecast for 2026-2028?

(NYSE: OGN) Organon & Co's forecast annual revenue growth rate of 1.09% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 9.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.

Organon & Co's revenue in 2026 is $6,216,000,000.On average, 9 Wall Street analysts forecast OGN's revenue for 2026 to be $1,624,890,287,300, with the lowest OGN revenue forecast at $1,569,703,369,500, and the highest OGN revenue forecast at $1,695,956,459,750. On average, 9 Wall Street analysts forecast OGN's revenue for 2027 to be $1,651,963,114,900, with the lowest OGN revenue forecast at $1,575,169,998,150, and the highest OGN revenue forecast at $1,760,254,425,300.

In 2028, OGN is forecast to generate $1,669,664,579,100 in revenue, with the lowest revenue forecast at $1,586,884,202,400 and the highest revenue forecast at $1,793,835,144,150.

What is OGN's forecast return on assets (ROA) for 2026-2029?

(NYSE: OGN) forecast ROA is 7.76%, which is lower than the forecast US Drug Manufacturers - General industry average of 27.43%.

What is OGN's Price Target?

According to 3 Wall Street analysts that have issued a 1 year OGN price target, the average OGN price target is $9.67, with the highest OGN stock price forecast at $12.00 and the lowest OGN stock price forecast at $8.00.

On average, Wall Street analysts predict that Organon & Co's share price could reach $9.67 by Feb 24, 2027. The average Organon & Co stock price prediction forecasts a potential upside of 51.28% from the current OGN share price of $6.39.

What is OGN's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: OGN) Organon & Co's current Earnings Per Share (EPS) is $0.72. On average, analysts forecast that OGN's EPS will be $3.50 for 2026, with the lowest EPS forecast at $3.25, and the highest EPS forecast at $3.91. On average, analysts forecast that OGN's EPS will be $3.76 for 2027, with the lowest EPS forecast at $3.46, and the highest EPS forecast at $4.14. In 2028, OGN's EPS is forecast to hit $4.21 (min: $3.73, max: $4.66).

What is OGN's forecast return on equity (ROE) for 2026-2029?

(NYSE: OGN) forecast ROE is 132.86%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.